← Cancer Treatment and Research Communications
Papers in Cancer Treatment and Research Communications
Page 4 · newest first
- Clinicopathological features and prognostic factors of pulmonary pleomorphic carcinomaCancer Treatment and Research Communications · 2026
- Immune checkpoint inhibitor (ICI) associated corneal allograft rejectionCancer Treatment and Research Communications · 2026
- Opium and opioid use and cancer risk: A systematic review and meta-analysis of epidemiological studiesCancer Treatment and Research Communications · 2026
- Prognostic impact of spread through air spaces (STAS) in mucin-producing lung adenocarcinoma: a multinational cohort studyCancer Treatment and Research Communications · 2026
- Engineering of ovine pancreatic RNase A as an Anti-tumor agent through in silico and experimental approachesCancer Treatment and Research Communications · 2026
- A comparative analysis of cytotoxic effects: Lactobacillus reuteri Extract vs. Newcastle Disease Virus in human colorectal cancer (HT-29 cell line)Cancer Treatment and Research Communications · 2026
- Recent advances in biomarkers, artificial intelligence, and targeted therapeutic strategies in breast cancer: Current progress and future perspectivesCancer Treatment and Research Communications · 2026
- Lymphatic extracellular vesicles and non-coding rnas in the melanoma sentinel lymph node pre-metastatic niche: Emerging lessons from aggressive skin cancersCancer Treatment and Research Communications · 2026
- Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironmentCancer Treatment and Research Communications · 2026
- Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancerCancer Treatment and Research Communications · 2026
- Fumarate hydratase-deficient renal cell carcinoma – results of the exploratory analysis in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line treatmentCancer Treatment and Research Communications · 2026
- Key target genes of miR-625-5p in colorectal cancer: uncovering novel therapeutic targets within regulatory networkCancer Treatment and Research Communications · 2026
- PPARγ activation sensitizes MSS gastrointestinal cancer cells to PD1 blockageCancer Treatment and Research Communications · 2026
- Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significanceCancer Treatment and Research Communications · 2026
- Molecular determinants of Bortezomib sensitivity and resistance in multiple myelomaCancer Treatment and Research Communications · 2026
- Role of circadian clock in oral squamous cell carcinoma pathogenesis and treatmentCancer Treatment and Research Communications · 2026
- Potential use of HOTAIR and MALAT1 as prognostic biomarkers for cervical cancer: An application to the NHSCancer Treatment and Research Communications · 2026
- Performance status 2 or higher in EMA labels for advanced non-small-cell lung cancer: a cross-sectional SmPC analysisCancer Treatment and Research Communications · 2026
- Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B studyCancer Treatment and Research Communications · 2026
- Impact of the COVID-19 pandemic on cancer screening in Europe: A systematic review of disruptions, barriers, and policy responsesCancer Treatment and Research Communications · 2026
- Role of microRNA-451a in molecular pathology of cancerCancer Treatment and Research Communications · 2026
- The association of glucose disposal rate on cancer odds mediated by composite inflammatory biomarkers: a cross-sectional studyCancer Treatment and Research Communications · 2026
- Long-term results of postoperative whole-breast irradiation plus simultaneous integrated boost (SIB) for adolescents and young adults (AYA) diagnosed with early breast cancer after undergoing breast-conserving surgery in a single instituteCancer Treatment and Research Communications · 2026
- Curcumin as a natural photosensitizer in photodynamic therapy: efficacy against metastatic melanoma cellsCancer Treatment and Research Communications · 2026
- Altered expression of ET-1 and HMGB1 together with higher MMP-9 activity in serum-derived exosomes of chronic lymphocytic leukemiaCancer Treatment and Research Communications · 2026
- Beyond the clinical trial: Real-world treatment patterns and drivers of PD-(L)1 therapy use in first-line metastatic NSCLCCancer Treatment and Research Communications · 2026
- Expression of PCAT19, miR-195, ITGA6, and E-cadherin in prostate cancer: a preliminary tissue-based studyCancer Treatment and Research Communications · 2026
- Gut microbiota regulating programmed cell death: Impacts on cancer immunotherapy, mechanisms, therapeutic responses and intervention strategiesCancer Treatment and Research Communications · 2026
- Efficacy and safety of first-line EGFR-TKI combined with chemotherapy versus EGFR-TKI monotherapy in patients with EGFR-mutant non-small cell lung cancer and liver metastases: A propensity score–matched analysisCancer Treatment and Research Communications · 2026
- Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studiesCancer Treatment and Research Communications · 2026
- Pertuzumab–Docetaxel–Trastuzumab regimen in HER2-positive metastatic breast cancer: Real-world data from IndiaCancer Treatment and Research Communications · 2026
- The association between greenness, walkability, and post-menopausal breast cancer risk in Alberta’s Tomorrow ProjectCancer Treatment and Research Communications · 2026
- Comprehensive molecular profiling of advanced NSCLC in Greek patients:A prospective HeCOG studyCancer Treatment and Research Communications · 2026
- Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysisCancer Treatment and Research Communications · 2026
- CRISPR-Cas9 gene editing approaches in colorectal cancer: Current progress and future prospectsCancer Treatment and Research Communications · 2026
- Epidemiological and pathological profile of gastric cancer: A 10-year cross-sectional study in Khorramabad, Western IranCancer Treatment and Research Communications · 2026
- Characterizing symptom patterns in early-onset colorectal cancer: insights from a national inpatient analysisCancer Treatment and Research Communications · 2026
- Synergistic regulation of tumor angiogenesis via flavonoid modulation of lncRNAs: Mechanistic insights and therapeutic potentialCancer Treatment and Research Communications · 2026
- Association of apolipoprotein A2 isoform index with demographic, behavioral, and clinical risk factors for pancreatic ductal adenocarcinoma in a single-center observational study: considerations for development of a pancreatic cancer screening algorithm?Cancer Treatment and Research Communications · 2026
- Mapping the mutational terrain of lung adenocarcinoma: A Danish cohort study of 880 patientsCancer Treatment and Research Communications · 2026
- Comparison of regorafenib and immunotherapy in colorectal cancer survival: A multicenter cohort studyCancer Treatment and Research Communications · 2026
- Diagnostic performance of pap smear for cervical intraepithelial neoplasia in women with treatment-resistant vaginal infections: A colposcopy-guided biopsy correlated studyCancer Treatment and Research Communications · 2026
- Application of landmark analysis and piecewise Cox regression to identify features associated with prognosis: A national retrospective cohort study of New Zealand womenCancer Treatment and Research Communications · 2026
- Conversion treatment with hepatic arterial infusion of oxaliplatin, leucovorin and fluorouracil plus intravenous bevacizumab or cetuximab for initially unresectable colorectal liver metastasis: A prospective studyCancer Treatment and Research Communications · 2026
- Traditional Chinese medicine-mediated ferroptosis in cancer therapy: mechanisms, advances, and nanotechnology-driven delivery strategiesCancer Treatment and Research Communications · 2026
- Characterization of POU2F3-expressing large cell neuroendocrine carcinoma of the lung: A comprehensive analysis of morphology, immunohistochemistry, and genomic alterationsCancer Treatment and Research Communications · 2026
- Non-Coding RNAs in breast cancer bone metastasis: Regulators and novel therapeutic targetsCancer Treatment and Research Communications · 2026
- Role of non-animal 3D models in H. pylori associated gastric carcinogenesis: Insights and future perspectivesCancer Treatment and Research Communications · 2026
- OTUB1/SLC7A11 axis promoted AKT signaling activation to mediate ovarian cancer progressionCancer Treatment and Research Communications · 2026
- Beyond hyponatremia: serum sodium below 137 mEq/L and postoperative sodium trajectory as prognostic markers in resected non-small cell lung cancerCancer Treatment and Research Communications · 2026